Home / Movies / FDA Commissioner: Are The Incentives Right For Orphan Drugs?

FDA Commissioner: Are The Incentives Right For Orphan Drugs?

Dr. Scott Gottlieb, Food and Drug Administration commissioner, told Kaiser Health News the incentives intended to spur development of drugs for rare diseases deserve a fresh look.

Food and Drug Commissioner Scott Gottlieb says he wants to know why drugmakers churn out medicines for some rare diseases but not others.

(Image credit: J. Scott Applewhite/AP)



from Stories from NPR : NPR http://ift.tt/2ByGgzd
FDA Commissioner: Are The Incentives Right For Orphan Drugs? FDA Commissioner: Are The Incentives Right For Orphan Drugs? Reviewed by digital manu on December 22, 2017 Rating: 5

You May Also Like

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.